Founded in 2002, the Institute of Pharmaceutical Sciences (ICF) is one of Brazil’s leading pharmaceutical research centres. ICF – a QIMA Life Sciences company was the first Brazilian laboratory certified for bioequivalence and bioavailability studies by ANVISA and is recognized across Latin America for its clinical and analytical expertise. ICF supports pharmaceutical companies throughout product development and regulatory submission.
ICF delivers clinical and analytical research services for pharmaceuticals.
Services include:
Bioequivalence and relative bioavailability studies
Clinical research (Phases I–IV)
Pharmacodynamic studies
Bioanalysis and analytical method development and validation
Pharmaceutical equivalence and quality control
Industries served include:
Pharmaceutical research and manufacturing
ICF is distinguished by its pioneering role in bioequivalence research, extensive clinical infrastructure and strong regulatory credibility. With hundreds of completed studies and a large inpatient facility, ICF combines scale with scientific and ethical rigor. Clients value its reliability, experience and longstanding regulatory trust. ICF stands out for its dedicated 86-bed unit, its in-house pharmacy, its fully integrated analytical laboratory, and its CDMO capabilities.
ICF is certified by ANVISA and the Chilean Institute of Public Health (ISP) and operates in compliance with ISO/IEC 17025 and applicable clinical research regulations.
As part of QIMA Life Sciences, ICF strengthens QIMA’s clinical research and bioequivalence capabilities in Latin America.
Contact our team to learn more about ICF’s pharmaceutical research services within QIMA Life Sciences.